CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor models
STAR Protocols(2022)
摘要
This protocol details the procedure for CRISPR-assisted insertion of epitopes (CRISPitope), a flexible approach for generating tumor cells expressing model CD8+ T cell epitopes fused to endogenously encoded gene products of choice. CRISPitope-engineered tumor cells can be recognized by T cell receptor-transgenic (TCRtg) CD8+ T cells that are widely used in immunology research. Using mice inoculated with CRISPitope-engineered tumor cells, researchers can investigate how the choice of the target antigen for T cell immunotherapies influences treatment efficacy and resistance mechanisms.For complete details on the use and execution of this protocol, please refer to Effern et al. (2020).
更多查看译文
关键词
Cell Biology,Flow Cytometry/Mass Cytometry,Cancer,Immunology,Model Organisms,Molecular Biology,CRISPR,Biotechnology and bioengineering
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要